These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 31387637

  • 21. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
    Wang Y, Sedimbi SK, Löfbom L, Besra GS, Porcelli SA, Cardell SL.
    Front Immunol; 2019; 10():352. PubMed ID: 30881361
    [Abstract] [Full Text] [Related]

  • 22. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
    Tagawa T, Wu L, Anraku M, Yun Z, Rey-McIntyre K, de Perrot M.
    J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
    [Abstract] [Full Text] [Related]

  • 23. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A, Apostolou I, Leite-De-Moraes M, Gombert JM, Garcia C, Koezuka Y, Bach JF, Herbelin A.
    J Immunol; 2000 Nov 01; 165(9):4917-26. PubMed ID: 11046017
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
    Cao Z, Yuan Y, Jeyabalan G, Du Q, Tsung A, Geller DA, Billiar TR.
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug 01; 297(2):G249-58. PubMed ID: 19556359
    [Abstract] [Full Text] [Related]

  • 28. Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice.
    Zhang J, Bi J, Ren Y, Du Z, Li T, Li Q, Ke M, Dong J, Lv Y, Wu R.
    Cytokine; 2018 Nov 01; 111():237-245. PubMed ID: 30195979
    [Abstract] [Full Text] [Related]

  • 29. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S, Shimizu K, Hemmi H, Steinman RM.
    Immunol Rev; 2007 Dec 01; 220():183-98. PubMed ID: 17979847
    [Abstract] [Full Text] [Related]

  • 30. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
    Kakimi K, Guidotti LG, Koezuka Y, Chisari FV.
    J Exp Med; 2000 Oct 02; 192(7):921-30. PubMed ID: 11015434
    [Abstract] [Full Text] [Related]

  • 31. Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
    Yoshiga Y, Goto D, Segawa S, Horikoshi M, Hayashi T, Matsumoto I, Ito S, Taniguchi M, Sumida T.
    Clin Exp Immunol; 2011 May 02; 164(2):236-47. PubMed ID: 21391989
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K.
    Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891
    [Abstract] [Full Text] [Related]

  • 34. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner.
    Coppieters K, Van Beneden K, Jacques P, Dewint P, Vervloet A, Vander Cruyssen B, Van Calenbergh S, Chen G, Franck RW, Verbruggen G, Deforce D, Matthys P, Tsuji M, Rottiers P, Elewaut D.
    J Immunol; 2007 Aug 15; 179(4):2300-9. PubMed ID: 17675491
    [Abstract] [Full Text] [Related]

  • 35. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K.
    Eur J Immunol; 2001 Jun 15; 31(6):1720-7. PubMed ID: 11385616
    [Abstract] [Full Text] [Related]

  • 36. Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.
    Ohtaki H, Ito H, Ando K, Ishikawa T, Saito K, Imawari M, Yokochi T, Moriwaki H, Seishima M.
    Biochem Biophys Res Commun; 2009 Jan 16; 378(3):579-83. PubMed ID: 19056341
    [Abstract] [Full Text] [Related]

  • 37. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.
    J Immunol; 2003 Nov 15; 171(10):5140-7. PubMed ID: 14607913
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer.
    Wang Y, Bhave MS, Yagita H, Cardell SL.
    Front Immunol; 2020 Nov 15; 11():581301. PubMed ID: 33193386
    [Abstract] [Full Text] [Related]

  • 40. Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer.
    Gebremeskel S, Lobert L, Tanner K, Walker B, Oliphant T, Clarke LE, Dellaire G, Johnston B.
    Cancer Immunol Res; 2017 Dec 15; 5(12):1086-1097. PubMed ID: 29054890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.